| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/13/2009 | CA2301032C A method of preventing or treating estrogen-dependent diseases and disorders |
| 01/13/2009 | CA2287907C Novel orally active iron (iii) chelators |
| 01/08/2009 | WO2009005671A2 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | WO2009005646A2 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | WO2009005645A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | WO2009005483A1 Method for treating metabolic syndrome x |
| 01/08/2009 | WO2009005469A2 The use of compounds such as pyridoxal derivatives for the treatment of diabetes or diseases associated with the metabolic syndrome |
| 01/08/2009 | WO2009005396A1 Cholesterol-control agent |
| 01/08/2009 | WO2009005115A1 Composition for promotion of reduction in size of adipocyte |
| 01/08/2009 | WO2009005076A1 Amide compound |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009004076A2 Supplemention of maternal diet |
| 01/08/2009 | WO2009003997A1 Imidazo [1, 2-c] pyrimidin-2-ylmethylpiperidines as orexin receptor antagonists |
| 01/08/2009 | WO2009003993A1 Piperidine derivatives useful as orexin receptor antagonists |
| 01/08/2009 | WO2009003681A1 Dpp-iv inhibitors |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/08/2009 | US20090012171 Novel Compounds, Their Preparation and Use |
| 01/08/2009 | US20090012168 Adiponection inducers or secretagogues |
| 01/08/2009 | US20090012160 such as 15-Ethoxycarbonyl-3,3,14,14-tetramethylpentadecanoyl-L-carnitine, for the treatment of cardiovascular, metabolic and gastrointestinal disorders, inflammation, cancer, anemia, Alzheimer's disease, modulating peroxisome proliferator-activated receptors, as microbiocides and viricides |
| 01/08/2009 | US20090012150 Stablized Pharmaceutical Composition Comprising an Amorphous Active Substance |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012142 Compositions and Methods for Increasing Lean Muscle Mass and/or Reducing Fat Gain |
| 01/08/2009 | US20090012131 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012119 Fluoroalkylpyrrolidine derivative |
| 01/08/2009 | US20090012114 Cyclohepta[B]Pyridine-3-Carbonylguanidine Derivative and Pharmaceutical Product Containing Same |
| 01/08/2009 | US20090012112 Alpha 1A-adrenoceptor antagonists |
| 01/08/2009 | US20090012097 Polycyclic 1,2,3,4-Tetrahydro-Isoquinoline Derivatives and Compositions Comprising Them As Ppar Modulators |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012091 Oximide derivatives and their therapeutical application |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012080 Sirtuin modulating compounds |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012069 Novel Antidiabetic Compounds |
| 01/08/2009 | US20090012067 Modulation of Hypothalamic Atp-Sensitive Potassium Channels |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012010 Amino acid derivatives as calcium channel blockers |
| 01/08/2009 | US20090012005 Use of an angiotensin IV antagonist to treat insulin resistance or cardiovascular risk related to metabolic syndrome |
| 01/08/2009 | US20090012001 Lipid metabolism-improving agent |
| 01/08/2009 | US20090011998 Calcium-influx inhibitory factor and method of isolation thereof |
| 01/08/2009 | US20090011994 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 01/08/2009 | US20090011985 Gh secretagogues and uses thereof |
| 01/08/2009 | US20090011976 Stable Formulations Of Peptides |
| 01/08/2009 | US20090011074 Satiety Emulsions And Food Compositions |
| 01/08/2009 | US20090011055 Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090010983 Alginate Coated, Polysaccharide Gel-Containing Foam Composite, Preparative Methods, and Uses Thereof |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010911 Methods and compositions for affecting cyclophilin a regulation of kinases in modulating cellular activities |
| 01/08/2009 | US20090010892 Hyperlipidemia Treatment Agent |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | US20090010882 Polymorphs of sodium 4-4[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 01/08/2009 | DE102007030695A1 Co-crystal, useful e.g. to prepare a pharmaceutical formulation for the treatment of psychosis, neurological disorder and struma lymphomatosa, comprises an amino compound and urea as further component |
| 01/08/2009 | CA2694264A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2694253A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2692355A1 Production and purification of esters of polyunsaturated fatty acids |
| 01/08/2009 | CA2692268A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2692265A1 Amide compounds |
| 01/08/2009 | CA2691721A1 Supplemention of maternal diet |
| 01/08/2009 | CA2691638A1 Piperidine derivatives useful as orexin receptor antagonists |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011788A1 Oxadiazolidinedione compound |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011506A1 Supplementation of maternal diet |
| 01/07/2009 | EP2011500A1 Fat accumulation inhibitor |
| 01/07/2009 | EP2011493A1 Inhibitor of increase in postprandial blood insulin level |
| 01/07/2009 | EP2010519A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 01/07/2009 | EP2010511A1 Chromen-2-one derivatives |
| 01/07/2009 | EP2010487A1 5-amido-2-carboxamide indoles |
| 01/07/2009 | EP2010485A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
| 01/07/2009 | EP2010483A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof |
| 01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/07/2009 | EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol |
| 01/07/2009 | EP2010186A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/07/2009 | EP2010176A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 01/07/2009 | EP2010012A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity |
| 01/07/2009 | EP1858867B1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 01/07/2009 | EP1807072B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/07/2009 | EP1797042B1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
| 01/07/2009 | EP1499277B1 Pyy3-36 for the reduction or prevention of obesity |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1345896B1 Crystalline forms of atorvastatin |
| 01/07/2009 | EP1292300B1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus |
| 01/07/2009 | EP1242103B1 Extracts derived from pueraria mirifica and extraction thereof |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | CN101341171A Therapeutic agent |
| 01/07/2009 | CN101340932A Carrier for medicaments for obtaining oral bioavailability |
| 01/07/2009 | CN101337989A Novel glucagon-like peptide-1(GLP-1) analogues and use thereof |
| 01/07/2009 | CN101337984A Bearberry type pentacyclic triterpenes amino acid derivates, method for preparing same and pharmaceutical use thereof |
| 01/07/2009 | CN101337920A Phenylalanyl pyrrolidine derivates, preparation method and application thereof |
| 01/07/2009 | CN101337871A Indandione compound |
| 01/07/2009 | CN101337075A Liquid state vitamine C and production method thereof |
| 01/07/2009 | CN101337057A Zhiqing granule and preparation method thereof |
| 01/07/2009 | CN101337052A Compound black-bone chicken paste for promoting accelerated development of fetus brain |